Published On: Tue, Mar 28th, 2017

Net Savings Link Inc (OTCMKTS:NSAV) Reports Share Reduction

Net Savings Link Inc (OTCMKTS:NSAV) reported that the firm has approved reduction of its authorized shares. The firm took this measured after extensive consultation with its attorneys, advisers and investment bankers, in order to guarantee that the quantum of the share reduction advantages all NSAV shareholders, while still permitting the firm to grow and close acquisitions.

The buzz

Net Savings intends to reassure all of its stockholders that no considerable dilution of its shares has been recorded or will take place. NSAV is not considering or even planning a reverse split. The firm reported that an additional 2.5 billion of its approved shares have been put on hold for likely cancellation. It wants to ensure that the authorized shares amount will allow NSAV to close its business plan and, in time, compensate a considerable share dividend to its stockholders.

Further, although the firm’s business model is developed by acquisition, the intent of NSAV is not to dilute shareholders while closing acquisitions. The firm’s objective is to compensate for its acquisitions out of the financial earnings of the firms it acquires. It even reported the launch of its social media website accounts.

James Tilton, the President of Net Savings, reported that they are extremely delighted that they can finally validate the long awaited dramatic decline of the company’s authorized shares. Once again, the management can assure all shareholders that this measure will benefit them. Tilton added that as he has mentioned on different occasions, he is fully committed to only taking measures that are in the best interest of shareholders. He wants to reaffirm that he does not own a single stock of NSAV common stock or any asset that converts into one share of common stock.

Mr. Tilton added that he sincerely expects that by putting a hold on additional authorized shares, they will alleviate the dilution concerns of many of their shareholders.

© Copyright 2016 OTC News Magazine. All rights reserved.